Interestingly, in patients with cancer, cachexia and weight loss — which are also common clinical features of patients with severe AH — are associated with GDF15 (19), and in mouse models, anti-GDF15 antibodies reverse cancer cachexia (20). This evidence concerns the gene GDF15 and cancer.